Pfizer and Alex Therapeutics to Provide Digital Solutions to German Patients
Digital therapies represent a huge growth area in German healthcare and have the potential to give many more patients access to a much broader selection of choice. Germany is one of the world's largest unified healthcare markets and now Pfizer and Alex Therapeutics have formed a collaboration in order to improve access. The collaboration will make clinically validated, evidenced-based therapies available to patients across Germany and provide a more personalised approach. Pfizer is renowned as being a cutting-edge pharmaceutical company...
View full press release